Ciclosporin aggravates tissue damage in ischemia reperfusion-induced acute pancreatitis

Pancreas

Volumn 32, Issue 2, 2006, Pages 145-151

  Hackert, Thilo ^a,c   Pfeil, Dagmar ^a   Hartwig, Werner ^a   Fritz, Stefan ^a   Gebhard, Martha Maria ^a   Klar, Ernst ^b   Werner, Jens ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c Department of Surgery ^*  (Germany)

Author keywords

Immunosuppression; Ischemia reperfusion; Pancreas transplantation; Pancreatitis

Indexed keywords

AMYLASE; CYCLOSPORIN; ENDOTHELIN 1; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; THROMBOXANE A2;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ERYTHROCYTE PARAMETERS; GRAFT PANCREATITIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; ISCHEMIA; LEUKOCYTE ADHERENCE; MALE; MICROCIRCULATION; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS NECROSIS; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THROMBOCYTE ADHESION; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; BLOOD PRESSURE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; HEART RATE; IMMUNOSUPPRESSIVE AGENTS; PANCREAS; PANCREAS TRANSPLANTATION; PANCREATITIS; RATS; REPERFUSION INJURY; TACROLIMUS;

EID: 33646051224     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000194610.62723.18     Document Type: Article

References (43)

1. Sutherland DE, Gruessner RW, Gruessner AC. Pancreas transplantation for treatment of diabetes mellitus. World J Surg. 2001;25:487-496.
2. Hopt UT, Drognitz O. Pancreas organ transplantation. Short and long-term results in terms of diabetes control. Langenbecks Arch Surg. 2000;385:379-389.
3. Chapman JR, Robertson P, Allen RD. Why do pancreas transplants thrombose? Transplantation. 2001;72:202-209.
4. Humar A, Ramcharan T, Kandaswamy R, et al. Technical failures after pancreas transplants: why grafts fail and the risk factors - a multivariate analysis. Transplantation. 2004;78:1188-1192.
5. Drachenberg CB, Abruzzo LV, Klassen DK, et al. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection. Hum Pathol. 1998;29:569-577.
6. Kaufman DB, Shapiro R, Lucey MR, et al. Immunosuppression: practice and trends. Am J Transplant. 2004;4(Suppl 9):38-53.
7. Freise CE, Kang SM, Feng S, et al. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg. 2003;138:1121-1125.
8. Nankivell BJ, Chapman JR, Bonovas G, et al. Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation. 2004;77:1457-1459.
9. Dieterle CD, Schmauss S, Veitenhansl M, et al. Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. Transplantation. 2004;77:1561-1565.
10. Bechstein WO, Malaise J, Saudek F, et al. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation. 2004;77:1221-1228.
11. Echigo Y, Inoue K, Kogire M, et al. Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. Arch Surg. 1995;130:64-68.
12. Ito T, Kimura T, Yamaguchi H, et al. Acute pancreatitis induced by cyclosporin A under stimulation of pancreas by caerulein. Pancreas. 1993;8:693-699.
13. Yamada T, Hashimoto T, Sogawa M, et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1397-G1404.
14. Mayer JM, Laine VJ, Gezgin A, et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. Eur J Surg. 2000;166:734-741.
15. Nieto Y, Russ P, Everson G, et al. Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. Bone Marrow Transplant. 2000;26:109-111.
16. Ito T, Kimura T, Furukawa M, et al. Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein. J Gastroenterol. 1994;29:305-313.
17. Massberg S, Enders G, Matos FC, et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood. 1999;94:3829-3838.
18. Butcher EC, Weissman IL. Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J Immunol Methods. 1980;37:97-108.
19. Baatz H, Steinbauer M, Harris AG. Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Artif Cells Blood Substit Immobil Biotechnol. 1994;22:587-592.
20. Khandoga A, Biberthaler P, Messmer K, et al. Platelet-endothelial cell interactions during hepatic ischemia-reperfusion in vivo: a systematic analysis. Microvasc Res. 2003;65:71-77.
21. Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215:44-56.
22. Hoffmann TF, Leiderer R, Waldner H, et al. Ischemia reperfusion of the pancreas: a new in vivo model for acute pancreatitis in rats. Res Exp Med (Berl). 1995;195:125-144.
23. Akita K, Ogawa M, Mandel TE. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice. Cell Transplant. 1994;3:61-73.
24. Ito T, Furukawa M, Liu X, et al. Immunosuppressive agents induce the reduction of local pancreatic blood flow. Pancreas. 1995;11:102-104.
25. Jansson L, Korsgren O, Wahlberg J, et al. Effects of cyclosporin A on the blood flow of the native and transplanted rat pancreas and duodenum. Transpl Int. 1993;6:143-147.
26. Watarai Y, Morita K, Shimoda N, et al. Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production. Transplant Proc. 2004;36:2130-2132.
27. vanRijen MM, Kuijf ML, Metselaar HJ, et al. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. Transplantation. 2002;73:1666-1672.
28. Gallego MJ, Zoja C, Morigi M, et al. Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions. Am J Kidney Dis. 1996;28:23-31.
29. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8:187-194.
30. Benz S, Bergt S, Obermaier R, et al. Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation. 2001;71: 759-763.
31. Schaser KD, Puhl G, Vollmar B, et al. In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation. Am J Transplant. 2005;5:341-350.
32. Klar E, Mall G, Messmer K, et al. Improvement of impaired pancreatic microcirculation by isovolemic hemodilution protects pancreatic morphology in acute biliary pancreatitis. Surg Gynecol Obstet. 1993;176:144-150.
33. Yamaguchi H, Weidenbach H, Luhrs H, et al. Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis. Gut. 1997;40:531-535.
34. Hackert T, Werner J, Gebhard MM, et al. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery. 2004;135:131-138.
35. Benz S, Busing M, Kruger B, et al. Pancreas graft thrombosis: is there a role for trypsin. Pancreas. 2004;28:75-79.
36. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246:339-346.
37. Taler SJ, Textor SC, Canzanello VJ, et al. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf. 1999;20:437-449.
38. Darlametsos IE, Varonos DD. Role of prostanoids and endothelins in the prevention of cyclosporine-induced nephrotoxicity. Prostaglandins Leukot Essent Fatty Acids. 2001;64:231-239.
39. Rincon J, Parra G, Quiroz Y, et al. Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness. Clin Exp Immunol. 2000;121:391-398.
40. Karlsson H, Nassberger L. FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. Transplantation. 1997;64:1217-1220.
41. Thomson AW, Nalesnik MA, Rilo HR, et al. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity. 1993;15:215-223.
42. Rafiee P, Johnson CP, Li MS, et al. Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium. J Biol Chem. 2002;277:35605-35615.
43. Aoyama T, Suehiro S, Hirai H, et al. Effects of FK506 on acute allograft rejection in transplanted rat heart: the role of mitogen-activated protein kinases, AP-1 and NF-kappaB. Osaka City Med J. 2003;49:1-10.